Nan Fung Group Holdings’s BioMarin Pharmaceuticals BMRN Stock Holding History

Nan Fung Group Holdings’s Portfolio BMRN Stock Details BMRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-10,815	Closed	-$760K	–	37
2024 Q3	$760K	Hold	10,815	–	–	0.65%	26
2024 Q2	$890K	Hold	10,815	–	–	0.95%	23
2024 Q1	$945K	Buy	10,815 +7,200	+199%	+$645K	0.88%	25
2023 Q4	$349K	Hold	3,615	–	–	0.22%	31
2023 Q3	$320K	Hold	3,615	–	–	0.26%	30
2023 Q2	$313K	Sell	3,615 -3,600	-50%	-$339K	0.2%	34
2023 Q1	$702K	Buy	7,215 +1,100	+18%	+$114K	0.48%	25
2022 Q4	$633K	Hold	6,115	–	–	0.44%	23
2022 Q3	$518K	Hold	6,115	–	–	0.33%	25
2022 Q2	$507K	Hold	6,115	–	–	0.35%	26
2022 Q1	$471K	Sell	6,115 -1,345	-18%	-$113K	0.22%	32
2021 Q4	$659K	Buy	+7,460	New	+$616K	0.2%	31

Other funds holding BMRN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Nan Fung Group Holdings's BMRN Position: Q4 2024 in Review

Nan Fung Group Holdings sold out of BioMarin Pharmaceuticals (BMRN) in Q4 2024, closing a stake of 10,815 shares — an estimated $760K sold.

Nan Fung Group Holdings first reported a position in BMRN in Q4 2021 and held it in 12 quarters. The position peaked at $945K in Q1 2024. 543 funds tracked by Wall St. Rank hold BMRN as of Q4 2024.

Nan Fung Group Holdings reported no remaining BioMarin Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Nan Fung Group Holdings sold 10,815 BioMarin Pharmaceuticals shares in Q4 2024, an estimated $760K.
Nan Fung Group Holdings first reported a position in BioMarin Pharmaceuticals in Q4 2021 and held it in 12 quarters.
Nan Fung Group Holdings's BioMarin Pharmaceuticals position peaked at $945K in Q1 2024.
543 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q4 2024.

Based on Nan Fung Group Holdings's 13F filing for Q4 2024, filed 13 Feb 2025.